3-Bromo-5-(N,N-dimethylaminomethyl)pyridine, 95+%, 500mg

4-Methyl-6-(2,4,4-trimethylpentyl)-2H-pyran-2-one, 98%, 1g

3-Fluoro-4-nitrobenzotrifluoride, 95.0%, 25g

1-(2-bromobenzoyl)piperazine, 95.0%, 1g

5-methyl-2-(trifluoromethyl)[1,2,4]triazolo[1,5-a]pyrimidin-7-amine, 95.0%, 10g

(3R,4S,5S,6S)-6-(METHOXYCARBONYL)TETRAHYDRO-2H-PYRAN-2,3,4,5-TETRAYL TETRAACETATE, 95.0%, 10g

Objetivo Plan S60x/0,80

2-Hydroxy-N-(5-nitro-2-thiazolyl)-benzamide, 90.0%, 1g

3,4-dihydro-1(2H)-quinolinyl(oxo)acetic acid, 95.0%, 5g

(R)-5-Bromo-3-[(1-methyl-2-pyrrolidinyl)methyl]-1H-indole, 95.0%, 100g

2-Butylmalonic acid, 95.0%, 5g

(2E)-3-[4-(benzyloxy)phenyl]-1-(2-chlorophenyl)prop-2-en-1-one, 95.0%, 2g

2-Amino-6-chloropyrazine>98.0%(GC)5g